BioSpace News Archive

Materials related to the presentation will be available at the same website at the start of the live webcast.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, has been invited to present at the 38th annual JP Morgan Healthcare Conference, which takes place in San Francisco January 13-16, 2020.

Aridis Pharmaceuticals, Inc. announced the appointment of Michael A. Nazak as its Chief Financial Officer effective January 1, 2020.

Alston & Bird, with over 800 attorneys, has offices in Atlanta, Beijing, Brussels, Charlotte, Dallas, London, Los Angeles, New York, Raleigh, San Francisco, Silicon Valley, and Washington, D.C.

The conference will be held at the Westin St. Francis Hotel in San Francisco, CA.

The conference will take place on January 14-15 2020 at the Lotte New York Palace Hotel.

Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that Anna Protopapas, President and Chief Executive Officer, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference

The conference will be held at the Hilton San Francisco Union Square.

Top-line data is expected in the first half of 2021.

Dicerna retains the right to opt into two clinical-stage programs to be derived from the discovery collaboration.